GB 001 - Zhejiang Echon Biopharm
Alternative Names: GB-001; GB-001 - Zhejiang Echon Biopharm; Recombinant-Peptide-SprayLatest Information Update: 31 May 2024
At a glance
- Originator Zhejiang Echon Biopharm
- Class Antiulcers; Peptides; Recombinant proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Aphthous stomatitis
Most Recent Events
- 25 Nov 2021 Preclinical trials in Aphthous stomatitis in China (PO) prior to November 2021
- 20 Nov 2021 Zhejiang Echon Biopharm plans a phase I trial in Aphthous stomatitis (In volunteers) in China (PO, Spray) (NCT05125211)